Compounds and methods for the treatment of cancer

Mérida Sotelo Lerma; R. A. Zingaro

Compounds and methods for the treatment of cancer

Mérida Sotelo Lerma (Inventor), R. A. Zingaro (Inventor)

Departamento de Investigación en Polímeros y Materiales

Resultado de la investigación: Patente

Resumen

The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.

Idioma original	Inglés estadounidense
Número de patente	7405314
CIP	US,20060128682
Fecha de prioridad	15/06/06
Fecha de introducción	29/07/08
Estado	Publicada - 29 jul 2008

Citar esto

@misc{64ea21cdb5e44f9f9eab4e6c005268ba,

title = "Compounds and methods for the treatment of cancer",

abstract = "The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.",

author = "{Sotelo Lerma}, M{\'e}rida and Zingaro, {R. A.}",

year = "2008",

month = jul,

day = "29",

language = "American English",

publisher = "The Texas A&M University System",

type = "Patent",

note = "7405314; US,20060128682",

}

TY - PAT

T1 - Compounds and methods for the treatment of cancer

AU - Sotelo Lerma, Mérida

AU - Zingaro, R. A.

PY - 2008/7/29

Y1 - 2008/7/29

N2 - The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.

AB - The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.

M3 - Patent

M1 - 7405314

Y2 - 2008/07/29

PB - The Texas A&M University System

ER -

Compounds and methods for the treatment of cancer

Resumen

Huella

Citar esto